Massive police raid in Rio favelas sparks nationwide protests over excessive force and high death toll.
Eli Lilly posts strong Q3 results, raises 2025 outlook, and expands patient access to its weight-loss drug Zepbound.
Novo Nordisk challenges Pfizer with a $6.5 billion bid for Metsera, offering a higher price and potential upside, but Pfizer denounces the proposal as 'reckless and unprecedented'.
Massive police raid in Rio favelas sparks nationwide protests over excessive force and high death toll.
Eli Lilly posts strong Q3 results, raises 2025 outlook, and expands patient access to its weight-loss drug Zepbound.
Novo Nordisk challenges Pfizer with a $6.5 billion bid for Metsera, offering a higher price and potential upside, but Pfizer denounces the proposal as 'reckless and unprecedented'.